4.5 Review

Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review

期刊

RADIATION ONCOLOGY
卷 15, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13014-020-01654-9

关键词

-

资金

  1. Munich Excellence Training Initiative for Physician Scientists (Metiphys)
  2. CPC-M translational funds (German Center for Lung Research (DZL))
  3. German Cancer Consortium (DKTK)
  4. DFG [GRK 2338]
  5. BMBF [02NUK047C]
  6. NIH/NCI Cancer Center Support Grant [P30 CA008748]

向作者/读者索取更多资源

Lung, breast, and esophageal cancer represent three common malignancies with high incidence and mortality worldwide. The management of these tumors critically relies on radiotherapy as a major part of multi-modality care, and treatment-related toxicities, such as radiation-induced pneumonitis and/or lung fibrosis, are important dose limiting factors with direct impact on patient outcomes and quality of life. In this review, we summarize the current understanding of radiation-induced pneumonitis and pulmonary fibrosis, present predictive factors as well as recent diagnostic and therapeutic advances. Novel candidates for molecularly targeted approaches to prevent and/or treat radiation-induced pneumonitis and pulmonary fibrosis are discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

An Inhibitory Function of TRPA1 Channels in TGF-β1-driven Fibroblast-to-Myofibroblast Differentiation

Fabienne Geiger, Sarah Zeitlmayr, Claudia A. Staab-Weijnitz, Suhasini Rajan, Andreas Breit, Thomas Gudermann, Alexander Dietrich

Summary: TRPA1 acts as an inhibitory factor in TGF-beta 1-driven fibroblast-to-myofibroblast differentiation and development of pulmonary fibrosis. Activation of TRPA1 channels can protect against the progression of pulmonary fibrosis by inhibiting TGF-beta receptor signaling.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2023)

Editorial Material Cell Biology

Is Zn2+ the new Ca2+ for TRPC6 channels in the myocardium?

Alexander Dietrich

Summary: Transient Receptor Potential (TRP) channels are nonselective cation channels that mainly allow the passage of Ca2+ and Na+, but some of them also permit the passage of Zn2+. A recent study discovered a Zn2+-dependent pathway involving the TRP member TRPC6 and alpha 1- as well as beta-adrenoceptors (AR) in rodent myocytes. This pathway, in which alpha 1-AR activation triggers Zn2+ influx through TRPC6 channels, enhances beta-AR-mediated positive inotropy and potentially benefits heart failure patients. This research highlights the importance of investigating the consequences of Zn2+ permeation through TRP channels in human health and disease.

CELL CALCIUM (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of a workflow for cone-beam CT-guided online adaptive palliative radiotherapy planned using diagnostic CT scans

Koen J. Nelissen, Eva Versteijne, Suresh Senan, Daan Hoffmans, Ben J. Slotman, Wilko F. A. R. Verbakel

Summary: A workflow involving preplanning on diagnostic CT imaging and online plan adaption using cone-beam CT scan was developed for single-visit radiotherapy. The study showed that this workflow can meet clinical goals and outperform initial treatment plans based on daily CT scan.

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2023)

Article Oncology

External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors

Ishita Chen, Abraham J. Wu, Andrew Jackson, Purvi Patel, Lian Sun, Angela Ng, Aditi Iyer, Aditya Apte, Andreas Rimner, Daniel Gomez, Joseph O. Deasy, Maria Thor

Summary: Pulmonary toxicity is a limiting factor in SBRT for tumors near PBT, esophagus, or other mediastinal structures. Published models of pulmonary toxicity were explored in an independent cohort of patients. Seven NTCP models were identified and the Dmax model best described pulmonary toxicity in this cohort.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Article Oncology

Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis

Andreas Rimner, Zachary R. Moore, Stephanie Lobaugh, Alexander Geyer, Daphna Y. Gelblum, Raja-Elie E. Abdulnour, Annemarie F. Shepherd, Narek Shaverdian, Abraham J. Wu, John Cuaron, Jamie E. Chaft, Marjorie G. Zauderer, Juliana Eng, Gregory J. Riely, Charles M. Rudin, Nicholas Vander Els, Mohit Chawla, Megan McCune, Henry Li, David R. Jones, Dennis M. Sopka, Charles B. Simone, Raymond Mak, Gerald L. Weinhouse, Zhongxing Liao, Daniel R. Gomez, Zhigang Zhang, Paul K. Paik

Summary: The purpose of the study was to investigate the efficacy and safety of nintedanib added to a prednisone taper in reducing pulmonary exacerbations in patients with radiation pneumonitis. The results showed that the addition of nintedanib to the treatment had a significant effect in reducing pulmonary exacerbations in RP patients.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy

Moritz Rabe, Miguel A. Palacios, John van Sornsen R. de Koste, Chukwuka Eze, Martin Hillbrand, Claus Belka, Guillaume Landry, Suresh Senan, Christopher Kurz

Summary: This study compared the accumulated doses of MRgRT, non-adaptive IMPT, and online adaptive IMPT for central lung tumors, with a focus on the bronchial tree dose. The results showed that non-adaptive and online adaptive proton therapy achieved significant dose sparing for organs in close proximity to central lung tumors compared to MRgRT. Online adaptive IMPT achieved significantly lower doses to the bronchial tree compared to MRgRT.

MEDICAL PHYSICS (2023)

Article Oncology

Same-day adaptive palliative radiotherapy without prior CT simulation: Early outcomes in the FAST-METS study

Koen J. Nelissen, Eva Versteijne, Suresh Senan, Barbara Rijksen, Marjan Admiraal, Jorrit Visser, Sarah Barink, Amy L. de la Fuente, Daan Hoffmans, Ben J. Slotman, Wilko F. A. R. Verbakel

Summary: We developed a rapid palliative radiotherapy workflow using diagnostic imaging for pre-planning and on-couch target and plan adaptation based on a synthetic CT obtained from CBCT. The adapted treatment plans showed significant improvements in target coverage compared to the original plans. Most patients were satisfied with the workflow. The average treatment time, including consultation and on-couch adaptive treatment, was 85 minutes.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Oncology

Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline

Puneeth Iyengar, Sean All, Mark F. Berry, Thomas P. Boike, Lisa Brad fi Eld, Anne -Marie C. Dingemans, Jill Feldman, Daniel R. Gomez, Paul J. Hesketh, Salma K. Jabbour, Melenda Jeter, Mirjana Josipovic, Yolande Lievens, Fiona Mcdonald, Bradford A. Perez, Umberto Ricardi, Enrico Ruffini, Dirk De Ruysscher, Hina Saeed, Bryan J. Schneider, Suresh Senan, Joachim Widder, Matthias Guckenberger

Summary: This guideline aims to review the use of local therapy in the management of extracranial oligometastatic non-small cell lung cancer (NSCLC) and provide recommendations. Currently, data is limited, but with increasing evidence supporting the use of local therapy in NSCLC, this guideline attempts to provide recommendations based on the quality of available data.

PRACTICAL RADIATION ONCOLOGY (2023)

Article Oncology

Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy

Hilal Tekatli, Miguel A. Palacios, Famke L. Schneiders, Cornelis J. A. Haasbeek, Ben J. Slotman, Frank J. Lagerwaard, Suresh Senan

Summary: This study investigated the long-term clinical outcomes of MR-guided SF-SABR on a 0.35 T linac for lung tumors. The results showed that SF-SABR, using automatic beam gating during breath-holds, achieved good tumor control and low toxicity.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Multidisciplinary Sciences

Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage

Christina Beck, Deepak Ramanujam, Paula Vaccarello, Florenc Widenmeyer, Martin Feuerherd, Cho-Chin Cheng, Anton Bomhard, Tatiana Abikeeva, Julia Schaedler, Jan-Peter Sperhake, Matthias Graw, Seyer Safi, Hans Hoffmann, Claudia A. A. Staab-Weijnitz, Roland Rad, Ulrike Protzer, Thomas Frischmuth, Stefan Engelhardt

Summary: The authors report on the development of a first-in-class, inhalable, carbohydrate-coupled microRNA-inhibitor that selectively targets macrophages and prevents pulmonary hyperinflammation. This inhibitor reverses pathological activation of macrophages and prevents pulmonary dysfunction and fibrosis in mice with acute lung damage. It also effectively prevents the exaggerated inflammatory response in human lung tissue infected with SARS-CoV-2 ex vivo.

NATURE COMMUNICATIONS (2023)

Article Oncology

Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk

Famke L. Schneiders, Claire van Vliet, Nicolas Giraud, Anna M. E. Bruynzeel, Ben J. Slotman, Miguel A. Palacios, Suresh Senan

Summary: This study retrospectively reviewed the outcomes of MR-guided adrenal SABR and found that this approach is well tolerated and achieves high local control rates. Further research using deformable dose accumulation is needed to better understand the dose-response relationship.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Article Oncology

Primer shot fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer

Z. A. R. Gouw, J. Jeong, A. Rimner, N. Y. Lee, A. Jackson, A. Fu, J-j. Sonke, J. O. Deasy

Summary: This study investigates the effectiveness of non-uniform fractionation schedules in radiotherapy for early-stage non-small cell lung cancer. Through modeling, optimized schedules are proposed to minimize local failures and toxicity risk. The results suggest that non-standard primer shot fractionation can reduce hypoxia-induced radioresistance and improve treatment outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Computer Science, Interdisciplinary Applications

ROE (Radiotherapy Outcomes Estimator): An open-source tool for optimizing radiotherapy prescriptions

Aditi Iyer, Aditya P. Apte, Ethan Bendau, Maria Thor, Ishita Chen, Jacob Shin, Abraham Wu, Daniel Gomez, Andreas Rimner, Ellen Yorke, Joseph O. Deasy, Andrew Jackson

Summary: This study developed an open-source software tool for radiotherapy prescriptions that can help healthcare providers determine prescriptions based on personalized dose-response curves, providing various functions including visualizing predicted tumor control and normal tissue complications, batch-mode tools, etc.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2023)

暂无数据